hum0252 Release Note
| Research ID | Release Date | Type of Data |
|---|---|---|
| hum0252.v3 | 2024/03/04 | NGS (Target Capture, scRNA-seq, scATAC-seq, ChIP-seq) |
| hum0252.v2 | 2023/12/06 | NGS (Target Capture, WGS, scRNA-seq, scATAC-seq, ChIP-seq) |
| hum0252.v1 | 2021/07/12 | NGS (Target Capture, RNA-seq, scRNA-seq) |
hum0252.v3
DNAs/RNAs extracted from non-tumor and tumor cells, or peripheral blood lymphocytes before and after valemetostat treatment from 8 ATL cases were used for the target capture sequencing, single cell RNA-seq, single cell ATAC-seq, and ChIP-seq analyses. Fastq files are provided.
hum0252.v2
DNAs/RNAs extracted from non-tumor and tumor cells, or peripheral blood lymphocytes before and after valemetostat treatment from 4 ATL cases and CD4+ T cells from healthy donors were used for the target capture sequencing, whole genome sequencing, single cell RNA-seq, single cell ATAC-seq, and ChIP-seq analyses. Fastq files are provided.
hum0252.v1
DNAs/RNAs extracted from infected cells and unifected cells of ATL and HTLV-1 carriers and CD4+ T cells from healthy donors were used for the target capture sequencing, RNA-seq, and single cell RNA-seq analyses. Fastq files are provided.
Note:
